Skip to main content
Explore URMC



John Jay Treanor, M.D.

Infectious Diseases

Clinical Interests

General Infectious Diseases

Contact Information

Phone Numbers

Office: (585) 275-5871

Fax: (585) 442-9328


Professional Background

Dr. Treanor is a graduate of the University of Rochester Medical School and a residency in Internal Medicine at the University of Vermont. He returned to the University of Rochester for Fellowship in Infectious Diseases and also trained at the Laboratory of Infectious Diseases, NIH. Dr. Treanor primarily sees inpatients with general ID problems at UR Medicine and has a small outpatient clinic.


My research interests are primarily focused on control of influenza with vaccines and antivirals, and on the safety and immunogenicity of vaccines for emerging infectious diseases. Our group currently conducts clinical studies evaluating candidate live attenuated influenza vaccines for prevention of pandemic influenza, and studies to document and evaluate the priming effects of pandemic vaccines on subsequent booster vaccines. As director of the New York Influenza Center of Excellence, I collaborate with colleagues in microbiology and immunology to perform detailed evaluations of the human humoral and cellular immune responses to influenza infection and vaccination. Our group is also active in clinical trials to evaluate new vaccines for Norovirus and other viral pathogens in the field and in the human experimental infection model.



  • Infectious Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


BA | Canisius College

MD | Univ Rochester Sch Med/Dent

Post-doctoral Training & Residency

07/01/1982 - 06/30/1985
Fellowship in Infectious Disease at Univ. of Rochester School of Medicine and Dentistry

07/01/1980 - 07/31/1982
Residency in Internal Medicine at Medical Center Hospital of Vermont

06/01/1979 - 06/30/1980
Internship in Internal Medicine at Medical Center Hospital of Vermont

VIEW ALL expand_more


Journal Articles

Nogales A, Piepenbrink MS, Wang J, Ortega S, Basu M, Fucile CF, Treanor JJ, Rosenberg AF, Zand MS, Keefer MC, Martinez-Sobrido L, Kobie JJ. "A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody." Scientific reports.. 2018 Mar 12; 8(1):4374. Epub 2018 Mar 12.

Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. "Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains." Proceedings of the National Academy of Sciences of the United States of America.. 2017 Nov 21; 114(47):12578-12583. Epub 2017 Nov 06.

Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL. "B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine." Clinical and vaccine immunology : CVI.. 2017 May 0; 24(5)Epub 2017 May 05.




Could Sugar Boost the Power of Some Antibiotics?


Flu Season 2010-11: A Crash Course


John Treanor, M.D.